EUROPE DRUG DISCOVERY MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE DRUG DISCOVERY MARKET FORECAST 2019-2027

EUROPE DRUG DISCOVERY MARKET FORECAST 2019-2027

The European drug discovery market contributed revenue of $XX million in 2018 and is estimated to generate $XX million by 2027. According to Inkwood Research, the market will proceed to grow with an expected 8.22% CAGR over the forecast period of 2019-2027. The increasing healthcare spending in European countries is influencing the drug discovery market in the region.

EUROPE DRUG DISCOVERY MARKET FORECAST 2019-2027

Europe Drug Discovery Market by Technology (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics and Pharmacogenetics, Combinatorial, Chemistry, Nanotechnology, Spectroscopy, Metabolomics, Other Technologies) by Drug Type (Small Molecule Drug, Biologic Drug) by Service (Drug Metabolism and Pharmacokinetics, (Dmpk) Services, Chemical Services, Biological Services, Other Pharmaceutical Services) by End User (Research Institutes, Pharmaceutical Companies, Contract Research Organizations (Cros), Other End User) by Geography.

Request free sample

The European drug discovery market contributed revenue of $XX million in 2018 and is estimated to generate $XX million by 2027. According to Inkwood Research, the market will proceed to grow with an expected 8.22% CAGR over the forecast period of 2019-2027. The increasing healthcare spending in European countries is influencing the drug discovery market in the region.

Growing prevalence of cardiovascular diseases, along with favourable government policies, are driving the growth of the drug discovery market in the region. Europe has been adopting the latest healthcare system to provide better care and treatment for patients. However, the delay in product launches due to drug regulations and norms is hindering the drug discovery market growth.

The Europe drug discovery market analysis encompasses countries such as Germany, Spain, France, Italy, the United Kingdom, and Rest of Europe regional segment, which includes remaining European countries. German drug discovery market is predicted to exhibit mounting growth owing to a better healthcare system. The country also has the presence of large biotechnology and pharmaceuticals companies that develops innovative technology and products, thereby boosting the drug discovery market.

Many prominent players operate in the drug discovery market; one of the leading players in the market is AstraZeneca PLC, which is a UK-based biopharmaceutical company. The company focuses on the development, discovery, and commercialization of prescription medicines that are used in the treatment of several diseases. It operates in numerous countries and has a wide range of products portfolio. Other companies include Bayer AG and Boehringer Ingelheim.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • HIGH PREVALENCE RATES OF MAJOR HEALTH DISORDERS
      • IMPLEMENTATION OF DRUG DISCOVERY PROGRAMS
      • BIOINFORMATICS IS THE WIDELY USED DRUG DISCOVERY TECHNOLOGY
      • SMALL MOLECULE DRUG TYPE CONSTITUTES THE HIGHEST MARKET SHARE
      • CONTRACT RESEARCH ORGANIZATIONS (CROS) ARE THE FASTEST-GROWING END USER
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • AGING POPULATION
      • BRANDED DRUGS ARE OUTPERFORMING DUE TO HIGH COST COMPARED TO GENERIC DRUGS
      • GROWING HEALTHCARE EXPENDITURE
      • TECHNOLOGICAL ADVANCEMENT
    • MARKET RESTRAINTS
      • DELAY IN PRODUCT LAUNCHES
      • POOR ACCESS TO HEALTHCARE SERVICES IN DEVELOPING MARKETS
      • SHIFT FROM BRANDED TO GENERIC DRUGS
    • MARKET OPPORTUNITIES
      • EXTENSIVE R & D FOR NEW PRODUCT LAUNCHES
      • INCREASING DEMAND FOR SPECIALTY MEDICINES
      • RISING INVESTMENT BY PHARMACEUTICAL COMPANIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
    • MARKET CHALLENGES
      • COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES
      • STRINGENT GOVERNMENT REGULATIONS
  1. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • BIOCHIPS
    • BIOINFORMATICS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • COMBINATORIAL CHEMISTRY
    • NANOTECHNOLOGY
    • SPECTROSCOPY
    • METABOLOMICS
    • OTHER TECHNOLOGIES
  2. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  3. MARKET BY SERVICE
    • DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
    • CHEMICAL SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  4. MARKET BY END USER
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS (CROS)
    • OTHER END USER
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREATS OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
    • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • PESTLE ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
  6. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. COMPANY PROFILES
    • 3M COMPANY
    • ANTARES PHARMA
    • ASTRAZENECA PLC
    • BAYER AG
    • BECTON, DICKINSON & COMPANY (BD)
    • BOEHRINGER INGELHEIM
    • ELI LILY
    • HOFFMANN-LA ROCHE LTD
    • GLAXOSMITHKLINE LLC
    • JOHNSON AND JOHNSON
    • MERCK & CO. INC.
    • NOVARTIS
    • PFIZER, INC.
    • SANOFI

 

LIST OF TABLES

TABLE 1        EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 2        EUROPE DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 3        EUROPE HIGH THROUGHPUT SCREENING MARKET, 2019-2027 ($ MILLION)

TABLE 4        EUROPE BIOCHIPS MARKET, 2019-2027 ($ MILLION)

TABLE 5        EUROPE BIOINFORMATICS MARKET, 2019-2027 ($ MILLION)

TABLE 6        EUROPE PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, 2019-2027 ($ MILLION)

TABLE 7        EUROPE COMBINATORIAL CHEMISTRY MARKET, 2019-2027 ($ MILLION)

TABLE 8        EUROPE NANOTECHNOLOGY MARKET, 2019-2027 ($ MILLION)

TABLE 9        EUROPE SPECTROSCOPY MARKET, 2019-2027 ($ MILLION)

TABLE 10      EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 11      EUROPE OTHER TECHNOLOGIES MARKET, 2019-2027 ($ MILLION)

TABLE 12      EUROPE DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)

TABLE 13      EUROPE SMALL MOLECULE DRUG MARKET, 2019-2027 ($ MILLION)

TABLE 14      EUROPE BIOLOGIC DRUG MARKET, 2019-2027 ($ MILLION)

TABLE 15      EUROPE DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)

TABLE 16      EUROPE DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 17      EUROPE CHEMICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 18      EUROPE BIOLOGICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 19      EUROPE OTHER PHARMACEUTICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 20      EUROPE DRUG DISCOVERY MARKET, BY END USER, 2019-2027 ($ MILLION)

TABLE 21      EUROPE RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)

TABLE 22      EUROPE PHARMACEUTICAL COMPANIES MARKET, 2019-2027 ($ MILLION)

TABLE 23      EUROPE CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, 2019-2027 ($ MILLION)

TABLE 24      EUROPE OTHER END USER MARKET, 2019-2027 ($ MILLION)

TABLE 25      EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

 

LIST OF FIGURES

FIGURE 1      EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 2      EUROPE DRUG DISCOVERY MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)

FIGURE 3      EUROPE DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)

FIGURE 4      EUROPE DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)

FIGURE 5      EUROPE DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)

FIGURE 6      EUROPE DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)

FIGURE 7      EUROPE DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)

FIGURE 8      EUROPE DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)

FIGURE 9      EUROPE DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)

FIGURE 10   EUROPE DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)

FIGURE 11   EUROPE DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)

FIGURE 12   EUROPE DRUG DISCOVERY MARKET SHARE BY DRUG TYPE 2018 & 2027 (%)

FIGURE 13   EUROPE DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)

FIGURE 14   EUROPE DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)

FIGURE 15   EUROPE DRUG DISCOVERY MARKET SHARE, BY SERVICE, 2018 & 2027 (%)

FIGURE 16   EUROPE DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION)

FIGURE 17   EUROPE DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 18   EUROPE DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 19   EUROPE DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 20   EUROPE DRUG DISCOVERY MARKET SHARE, BY END USER, 2018 & 2027 (%)

FIGURE 21   EUROPE DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)

FIGURE 22   EUROPE DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)

FIGURE 23   EUROPE DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)

FIGURE 24   EUROPE DRUG DISCOVERY MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)

FIGURE 25   PORTER’S FIVE FORCE MODEL

FIGURE 26   EUROPE DRUG DISCOVERY MARKET, REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 27   THE UNITED KINGDOM DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 28   FRANCE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 29   GERMANY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 30   SPAIN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 31   ITALY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 32   REST OF EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • BIOCHIPS
    • BIOINFORMATICS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • COMBINATORIAL CHEMISTRY
    • NANOTECHNOLOGY
    • SPECTROSCOPY
    • METABOLOMICS
    • OTHER TECHNOLOGIES
  2. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  3. MARKET BY SERVICE
    • DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
    • CHEMICAL SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  4. MARKET BY END USER
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS (CROS)
    • OTHER END USER

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now